---
title: "WBDE: Subsidiary's product has received orphan drug designation in the United States"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262845770.md"
description: "On October 27th, WBDE announced that its wholly-owned subsidiary, WBDE Pharmaceutical Group Co., Ltd., recently received a recognition letter from the U.S. Food and Drug Administration (FDA), granting orphan drug designation for WP203A for the treatment of pemphigus. Pemphigus is a severe autoimmune blistering disease characterized by widespread loose blisters and erosions on the skin and mucous membranes"
datetime: "2025-10-27T08:42:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262845770.md)
  - [en](https://longbridge.com/en/news/262845770.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262845770.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262845770.md) | [繁體中文](https://longbridge.com/zh-HK/news/262845770.md)


# WBDE: Subsidiary's product has received orphan drug designation in the United States

On October 27th, WBDE announced that its wholly-owned subsidiary, WBDE Pharmaceutical Group Co., Ltd., recently received a recognition letter from the U.S. Food and Drug Administration (FDA), granting orphan drug designation for WP203A for the treatment of pemphigus. Pemphigus is a severe autoimmune blistering disease characterized by widespread loose blisters and erosions on the skin and mucous membranes

### Related Stocks

- [WBDE (002082.CN)](https://longbridge.com/en/quote/002082.CN.md)

## Related News & Research

- [08:27 ETNew Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment](https://longbridge.com/en/news/278555841.md)
- [Ray Dalio issues final warning investors cannot afford to ignore](https://longbridge.com/en/news/279040930.md)
- [The Naderi Center Introduces Advanced PRF Injections Using the EZPRF Platform](https://longbridge.com/en/news/278879007.md)
- [Pioneering Dermocosmetics Brand Solaana MD, with Patented High-Absorption Topical Vitamin D Technology, Offered for Acquisition](https://longbridge.com/en/news/278568007.md)
- [CATL makes progress on its solid-state battery](https://longbridge.com/en/news/279018020.md)